Table 1 Patient characteristics

From: Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group

Characteristic

No. of patients

%

Age (years)

 <3

8

29

 3–5

13

46

 6–10

4

14

 11–18

3

11

Sex

 Male

16

57

 Female

12

43

Weight (kg)

 <10

1

3

 10–20

21

75

 20–30

3

11

 >30

3

11

Disease stage

 3 (with MYCN amplification)

2

7

 4 (age >1 year)

26

93

MYCN amplification

 Yes

15

54

 No

13

46